Valeritas is a Contributing Supporter of the Interactive Insulin Workshop at MEDS East Summit
11. Oktober 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, a simple,...
Persistent Use of Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrates Significant Clinical & Economic Benefits Compared to Conventional Insulin Delivery in Patients with Type 2 Diabetes
10. Oktober 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 10, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas’ V-Go® Demonstrates Benefits Versus Multiple Daily Injections in Patients with Type 2 Diabetes
02. Oktober 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Oct. 02, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of the V-Go® Wearable Insulin Delivery device, a simple,...
Valeritas Begins Medical Device Registration Process in China for Its V-Go® Wearable Insulin Delivery Device
26. September 2018 08:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces that V-Go® Insulin Delivery Device Has Launched in Australia
23. August 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, affordable,...
Valeritas Reports Record Second Quarter Revenue with 36% Year-over-Year Growth
07. August 2018 16:05 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, affordable,...
Valeritas Announces V-Go® Distribution Agreement in Czech Republic and Slovakia
06. August 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas’ V-Go® Wearable Insulin Delivery Device Demonstrated Improved Clinical Benefits in Patients with Uncontrolled Type 2 Diabetes Previously Treated with Multiple Daily Injections
02. August 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas Announces that V-Go® Insulin Delivery is Now Available in New Zealand
01. August 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one,...
Valeritas, Makers of V-Go® Insulin Delivery, is a Contributing Supporter of the Interactive Insulin Workshop at Two MEDS Conferences
25. Juli 2018 07:00 ET
|
Valeritas, Inc.
BRIDGEWATER, N.J., July 25, 2018 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ:VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device for patients with...